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Abstract
Aims/hypothesis. We sought to evaluate the impact of
diabetes mellitus on long-term outcome in patients
with unstable angina and non-ST-segment elevation
myocardial infarction treated with a very early inva-
sive strategy.
Methods. We carried out a prospective cohort study in
270 diabetic and 1163 non-diabetic patients with unsta-
ble angina and non-ST-segment elevation myocardial in-
farction. All patients underwent coronary angiography
and, if appropriate, subsequent revascularisation within
24 hours of admission. The primary endpoint was all-
cause mortality during follow-up for up to 60 months.
Results. Diabetic patients had less favourable baseline
characteristics including more advanced coronary ar-
tery disease and more severe unstable angina and non-
ST-segment elevation myocardial infarction. Percutane-
ous coronary intervention was performed in 53% of di-
abetic patients and 56% of non-diabetic patients. Coro-
nary artery bypass grafting was done in 21% of diabetic
patients and 12% of non-diabetic patients. In-hospital
mortality (4.1% vs 1.3%; hazard ratio 3.47; 95% CI:
1.57 to 7.64; p=0.002) and long-term mortality (9.7%
vs 4.9%; hazard ratio 2.11; 95% CI: 1.33 to 3.36;
p=0.002) were significantly higher in diabetic patients.
After adjustment for differences in baseline characteris-
tics, diabetes mellitus was no longer an independent
predictor of long-term mortality (hazard ratio 1.43;
95% CI: 0.74 to 2.78; p=0.292).
Conclusions/interpretation. Diabetic patients treated
with a very early invasive strategy for unstable angina
and non-ST-segment elevation myocardial infarction
have a higher in-hospital and long-term mortality that
is largely explained by their less favourable baseline
characteristics including more advanced coronary ar-
tery disease and more severe unstable angina and non-
ST-segment elevation myocardial infarction.
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Introduction
Diabetes mellitus is an important risk factor for coro-
nary artery disease, which is associated with increased
mortality and morbidity in diabetic patients as com-
pared with non-diabetic patients [1, 2, 3]. Patients
with diabetes mellitus with no history of coronary ar-
tery disease have the same risk of cardiovascular
death as non-diabetic patients with a history of myo-
cardial infarction [4]. In addition, patients with diabe-
tes mellitus have not experienced the reduction in 
cardiovascular mortality rates that has recently been
observed in non-diabetic subjects [5]. The number of
adults with diabetes mellitus worldwide is likely to
grow from 135 million in 1995 to approximately 300
million in 2025 [6]. However, only limited informa-
tion is available regarding the outcome of diabetic pa-
tients after hospital admission with unstable angina
and non-ST-segment elevation myocardial infarction
(UA/NSTEMI), the most common reason for admis-
sion to a coronary care unit [7, 8, 9, 10, 11]. The 
OASIS registry prospectively collected data from
UA/NSTEMI patients treated with predominately
medical therapy in six different countries including
the United States, and reported that diabetes mellitus
independently predicted mortality [11]. Overall, cu-
mulative mortality in patients with diabetes mellitus
was 19% at 24 months in the OASIS registry.
Revascularisation, irrespective of the primary suc-
cess of medical therapy, has become the preferred
treatment strategy in patients with UA/NSTEMI [12,
13, 14]. Current practice guidelines for the manage-
ment of patients with UA/NSTEMI from the American
College of Cardiology, the American Heart Associa-
tion, and the European Society of Cardiology recom-
mend an early invasive strategy for most patients [15,
16]. The long-term outcome of patients with diabetes
mellitus and UA/NSTEMI treated with a very early in-
vasive strategy remains to be assessed. We sought to
determine the long-term outcome of systematic revas-
cularisation within 24 hours in diabetic patients. In ad-
dition, we evaluated whether the prognostic impact of
diabetes mellitus is different between women and men.
Subjects and methods
Study population. From January 1996 to December 1999, con-
secutive patients admitted to our centre with UA/NSTEMI
were treated with a very early invasive strategy. Patients were
eligible for inclusion in this study if they underwent coronary
angiography for symptoms of myocardial ischaemia occurring
at rest (Braunwald class IIIB unstable angina) [17]. We exclud-
ed patients who had the following conditions: (i) a first case of
angina pectoris during exertion, or worsening angina during
exertion (Braunwald class 1A–C); (ii) persistent ST-elevation;
or (iii) postinfarction angina (Braunwald class 1C, 2C, 3C).
Also excluded were patients in whom angiography was not
performed due to patient refusal (n=6) or extremely severe
concomitant disease (n=9 with severe dementia or advanced
malignancy). The study was carried out in accordance with the
Declaration of Helsinki and approved by the institutional re-
view board. Informed consent was obtained from all participat-
ing patients. Diabetes was defined as the patient having a
known history of diabetes mellitus treated currently with either
diet intervention, oral glucose-lowering agents or insulin. Irre-
spective of the presence or absence of diabetes, strict gly-
caemic control was observed in all patients. Upon hospital dis-
charge, all patients were instructed to follow a low-cholesterol
diet, and statins were recommended to achieve an LDL choles-
terol lower than 2.6 mmol/l during follow-up. All patients 
received aspirin and beta blockers unless contraindicated.
Very early invasive strategy. Patients with persistent chest 
pain underwent immediate coronary angiography. In patients
asymptomatic while on medical therapy, coronary angiography
was performed within 24 hours of admission. Whenever possi-
ble, coronary stenting of the culprit lesion was done directly
after angiography. Stenting was not restricted to patients with
one- and two-vessel disease, but also favoured in patients with
three-vessel disease, if the target lesion seemed accessible. If
percutaneous coronary intervention was not possible (unpro-
tected left main disease, diffuse three-vessel disease) but revas-
cularisation seemed necessary, patients were scheduled for 
urgent coronary artery bypass grafting.
Follow-up. All patients were scheduled for outpatient visits at
6 months. In addition, patients were contacted by questionnaire
in September 2000, 4 years and 9 months after enrolment of
the first patient. For patients reporting cardiac symptoms, at
least one clinical and ECG examination was performed in the
outpatient clinic or by the referring physician. All information
derived from contingent hospital re-admission records and that
provided by the referring physician or by the outpatient clinic
was reviewed and entered into the computer database.
Endpoints and statistical analysis. The pre-specified primary
endpoint was defined as death from all causes. As secondary
endpoints we assessed non-fatal myocardial infarction and 
the composite of death and non-fatal myocardial infarction.
Myocardial infarction was defined as typical chest pain at rest
followed by an increase in creatine phosphokinase (CK and 
CK-MB more than two times the upper limit of normal, and
more than five times the upper limit of normal after coronary ar-
tery bypass grafting) or new Q waves in the ECG. To meet this
endpoint criterion, patients who initially had myocardial infarc-
tion had to develop ST-segment changes and an increase in CK
of at least 50% over the previous trough level in at least two
samples reaching at least three times the upper limit of normal.
Follow-up events were adjudicated by a clinical events
committee. All patients received ECG recordings directly after
percutaneous coronary intervention or coronary artery bypass
grafting and on the following morning. In addition, cardiac
markers (CK and CK-MB) were determined between 8 and 
24 hours after the intervention, and additionally whenever
ischaemic symptoms developed. The statistical analyses were
performed using the SPSS/PC (version 11.0; SPSS, Chicago,
Ill., USA) software package. Discrete variables were expressed
as percentages (95% CI) and continuous variables were ex-
pressed as means ± SD. A p value of 0.05 or less was consid-
ered statistically significant. For the rarer outcomes, confi-
dence intervals were calculated using the Wilson method.
Comparisons were made using ANOVA for independent sam-
ples and chi square tests as appropriate. All hypothesis testing
was two-tailed. Cox proportional hazards regression analysis
was used as the appropriate method throughout. Multivariate
Cox regression analysis was performed to identify independent
predictors of death. Baseline characteristics, ECG findings,
markers of inflammation and myocardial necrosis, and the an-
giographic extent of coronary artery disease were entered into
the model. The cumulative survival curves were constructed by
the Kaplan–Meier method.
Results
Baseline characteristics. There were 270 patients with
diabetes and 1163 patients without diabetes in this
study. The vast majority of diabetic patients were clas-
sified as having Type 2 diabetes (261 of the 270, 97%).
Besides diet and exercise, therapy included insulin in
74 (28%) of the 261 patients, and glibenclamide in 50
(19%) of the 261 patients. Baseline characteristics
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were considerably different between diabetic and non-
diabetic patients (Tables 1 and 2). Diabetic patients
were older, more often hypertensive and less often
smokers, and they more frequently had a previous
myocardial infarction as well as cardiac arrest during
the UA/NSTEMI leading to admission than non-dia-
betic patients. They also had a higher incidence of new
ST-segment depression and raised troponin T.
Angiographic characteristics and revascularisation.
Coronary angiography revealed that coronary artery
disease was more extensive in diabetic patients. More
than half of the patients with diabetes mellitus had
three-vessel disease compared with 35% of patients
without diabetes mellitus. Conversely, non-diabetic pa-
tients were two times as likely to have no coronary ves-
sel with a high-grade lesion as diabetic patients. Ac-
cordingly, coronary artery bypass grafting was chosen
significantly more often (21% vs 12%, p=0.001) in pa-
tients with diabetes. However, percutaneous coronary
intervention was the predominant revascularisation pro-
cedure in both groups. Percutaneous coronary interven-
tion was performed in 53% of patients with diabetes
and in 56% of patients without diabetes. Altogether,
two-thirds of patients underwent revascularisation.
In-hospital and long-term outcome. Patients with diabe-
tes mellitus had a significantly higher in-hospital mor-
tality rate than patients without diabetes mellitus (4.1%
vs 1.3%; hazard ratio 3.47; 95% CI: 1.57 to 7.64). In ad-
dition, non-fatal Q-wave myocardial infarction and the
combined endpoint of death or myocardial infarction
was recorded more frequently during the initial hospital-
isation in patients with diabetes mellitus (Table 3).
Table 1. Baseline patient characteristics
Diabetic patients (n=270) Non-diabetic patients (n=1163) p value
Age (years) 68±9 64±11 <0.001
Female sex 31 (25–36) 28 (26–31) 0.407
Previous myocardial infarction 41 (36–47) 31 (28–34) 0.001
Previous coronary bypass grafting 16 (11–20) 13 (11–15) 0.339
Previous coronary angioplasty 22 (17–27) 22 (20–25) 0.858
Hypercholesterolaemia 64 (58–69) 66 (63–69) 0.451
Hypertension 75 (70–80) 59 (56–62) 0.001
Smoking 14 (9–18) 25 (22–27) 0.001
Angina pectoris at rest >48 h 16 (12–20) 17 (15–19) 0.616
Angina pectoris at rest <48 h 67 (61–73) 69 (66–72) 0.522
Non-Q-wave myocardial infarction 17 (13–22) 14 (12–16) 0.167
Cardiopulmonary resuscitation 3.0 (0.9–5.0) 0.9 (0.4–1.5) 0.009
Defibrillation (only) 2.6 (0.7–4.5) 1.5 (0.8–2.3) 0.238
Cardiogenic shock 1.1 (0–2.4) 0.9 (0.3–1.4) 0.695
New ST depression at entry 14 (10–18) 10 (8–12) 0.090
New T-wave inversion 28 (23–34) 29 (27–32) 0.703
Troponin T ≥0.01 µg/l 63 (56–69) 55 (51–58) 0.047
C-reactive protein >10 mg/l 30 (24–37) 25 (22–28) 0.112
Creatinine (µmol/l) 91±74 80±59 0.016
White blood cell count (×103/µl) 9.0±3.0 8.8±8.0 0.820
Platelet count (×103/µl) 236±94 235±70 0.874
Data are expressed as means ± SD, or percentages (95% CI)
Table 2. Baseline angiographic and procedural characteristics
Diabetic patients (n=270) Non-diabetic patients (n=1163) p value
Coronary vessels with ≥50% stenosis 0.001
0 7 (4–10) 15 (13–17) 0.001
1 19 (14–24) 26 (24–29) 0.023
2 21 (16–26) 24 (21–26) 0.367
3 53 (46–59) 35 (32–38) 0.001
Percutaneous coronary intervention 53 (47–59) 56 (53–59) 0.278
Proportion with stent 74 (66–82) 81 (78–84) 0.094
Proportion with abciximab 12 (6–18) 11 (9–14) 0.931
Coronary artery bypass grafting 21 (17–26) 12 (10–14) 0.001
Medical therapy 26 (21–31) 31 (29–34) 0.075
Data are expressed as percentages (95% CI)
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The mean interval between admission and last pa-
tient contact or death was 19 months in diabetic pa-
tients and 20 months in non-diabetic patients. During
follow-up, mortality was significantly higher in pa-
tients with diabetes mellitus than in patients without
diabetes mellitus (Fig. 1). Kaplan–Meier analysis re-
vealed a cumulative survival rate of 86.6% for dia-
betic patients and 92.8% for non-diabetic patients at
36 months. The incidence of non-fatal myocardial in-
farction was similar in the two groups.
Association between diabetes mellitus and sex. As
shown in Figures 2 and 3, the impact of diabetes 
mellitus on long-term outcome was considerably dif-
ferent between men and women (p=0.001 for associa-
tion). While diabetic men showed a marked reduction
in survival rate compared with men without diabetes
(83.7% vs 92.4% at 36 months), diabetic women
showed a very similar survival rate to women without
diabetes mellitus (93.9% vs 93.7% at 36 months).
Diabetes mellitus and very early percutaneous coro-
nary intervention. The long-term survival rate in pa-
tients undergoing very early revascularisation with
percutaneous coronary intervention was excellent, ir-
respective of the presence or the absence of diabetes
mellitus (Fig. 4). At 36 months, the cumulative sur-
vival rate was 92.4% in diabetic patients and 92.0% in
non-diabetic patients.
Multivariate Cox regression analysis. After adjust-
ment for baseline characteristics, ECG findings, mark-
Table 3. Association between diabetes mellitus and outcome
Diabetic patients Non-diabetic patients Hazard ratio p value
(n=270) (n=1163) (95% CI)
In-hospital
Death 4.1 (2.1–7.2) 1.3 (0.7–2.1) 3.47 (1.57–7.64) 0.002
Death or myocardial infarctiona 7.8 (4.9–11.6) 3.7 (2.7–4.9) 2.41 (1.40–4.15) 0.002
Q-wave myocardial infarction 1.1 (0.2–3.2) 0.3 (0.1–0.8) 4.44 (0.90–21.99) 0.068
Non-Q-wave myocardial infarction 2.6 (1.0–5.3) 2.2 (1.5–3.3) 1.34 (0.54–3.32) 0.535
During follow-up
Death 9.6 (6.4–13.8) 4.9 (3.7–6.3) 2.11 (1.33–3.36) 0.002
Death or myocardial infarctiona 13.7 (9.8–18.4) 8.6 (7.1–10.4) 1.76 (1.20–2.59) 0.004
Myocardial infarction 4.4 (2.3–7.6) 4.0 (3.0–5.3) 1.21 (0.62–2.36) 0.570
Data are expressed as percentages (95% CI) unless otherwise stated. a Counting only one event per patient
Fig. 1. Cumulative survival in diabetic and non-diabetic pa-
tients during long-term follow-up. p=0.0016 by log-rank
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ers of inflammation and myocardial necrosis, and the
angiographic extent of coronary artery disease, diabe-
tes mellitus was not found to be a significant indepen-
dent predictor of long-term mortality (hazard ratio
1.43; 95% CI: 0.74 to 2.78; p=0.292). Adding very
early percutaneous coronary intervention as a variable
to the multivariate Cox regression analysis showed
that very early percutaneous coronary intervention
was independently associated with a favourable out-
come (hazard ratio for long-term mortality 0.50; 95%
CI: 0.30 to 0.85; p=0.011). This association would
persist if the analysis was restricted to diabetic pa-
tients only (hazard ratio 0.47; 95% CI: 0.20 to 1.09;
p=0.078).
Fig. 2. Cumulative survival in diabetic and non-diabetic men. p=0.0010 by log-rank
Fig. 3. Cumulative survival in diabetic and non-diabetic women.
p=0.5792 by log-rank
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Discussion
Our study of 1433 consecutive patients with UA/
NSTEMI treated with a very early invasive strategy
showed that in-hospital and long-term mortality were
significantly higher in patients with diabetes. This
finding is consistent with previous studies that primar-
ily used a conservative management strategy for
UA/NSTEMI [7, 8, 9, 10, 11]. Nevertheless, as our
major novel finding we were able to attribute most of
this excess risk to two factors: more advanced coro-
nary artery disease and more severe UA/NSTEMI at
presentation. In fact, we could demonstrate that after
adjusting for cofounders, diabetes mellitus was no
longer an independent predictor of adverse outcome
with this aggressive revascularisation strategy. We
found important differences in baseline characteristics
between diabetic and non-diabetic patients. Most im-
portantly, diabetic patients were older and more often
had previous myocardial infarction and three-vessel
disease. In addition, the UA/NSTEMI seemed to be
more severe in diabetic patients. Cardiopulmonary 
resuscitation, ST-segment depression and elevated 
troponin T were seen more often in diabetic patients
than in non-diabetic patients. When we adjusted for
these differences between diabetic and non-diabetic
patients, the presence or absence of diabetes mellitus
was no longer predictive of survival. As coronary 
angiography was performed in all patients, this study
Fig. 4. Cumulative survival in diabetic and non-diabetic pa-
tients revascularised very early with percutaneous coronary 
intervention. p=0.4242 by log-rank
was able to include the angiographic extent of coro-
nary artery disease in the multivariate model to assess
independent predictors of long-term mortality. We
found that the association of three-vessel disease 
and diabetes constitutes an important component of
the predictive power of diabetes by univariate analy-
sis.
This was not a randomised trial evaluating the very
early invasive strategy. Accordingly, any comparison
of the outcome observed in this prospective trial with
historical controls has inherent limitations and should
be interpreted with considerable caution. Although
very similar with respect to patient baseline character-
istics and study period, our study population experi-
enced merely two-thirds the mortality at 24 months of
that observed in the OASIS registry [11]. In our study,
particularly in the patients revascularised very early
with percutaneous coronary intervention, there was an
excellent outcome irrespective of the presence or ab-
sence of diabetes mellitus. In fact, in the subgroup re-
ceiving very early percutaneous coronary intervention,
long-term survival was identical in diabetic and non-
diabetic patients. This observation is supported by
subgroup analyses of the TACTICS-TIMI 18 and
FRISC II studies [12, 13], in which diabetic patients
showed a more pronounced benefit from the early 
invasive strategy than non-diabetic patients. In the
TACTICS-TIMI 18 study, the early invasive strategy
reduced the primary endpoint of death, non-fatal myo-
cardial infarction, or re-hospitalisation, for an acute
coronary syndrome at 6 months, from 27.7% to 20.1%
in diabetic patients, and from 16.4% to 14.2% in non-
diabetic patients. Our finding, however, can only be
used to generate hypotheses and needs to be con-
firmed by further study.
Excessive restriction during coronary angiography
and revascularisation procedures may have contribut-
ed significantly to the dismal prognosis of patients
with diabetes mellitus in earlier reports [5, 7, 11]. In a
case-control study of 162 diabetic patients with unsta-
ble angina, diabetic patients less frequently underwent
coronary angiography and angioplasty [7]. This obser-
vation was confirmed in the large OASIS registry. Al-
though the diabetic patients in the registry were at
clearly higher risk, having had more previous cardio-
vascular events including myocardial infarction, con-
gestive heart failure and coronary artery bypass graft-
ing, the rate of coronary angiography (37% vs 37%)
and revascularisation by percutaneous coronary inter-
vention or coronary artery bypass grafting (23% vs
20%) was not appropriately increased in patients with
diabetes compared with patients without diabetes. In
marked contrast, 70% of patients underwent revascu-
larisation in this study. It is possible that at least partly
as a result of this difference, 2-year mortality in pa-
tients with diabetes in the OASIS registry was in-
creased by 50% compared with diabetic patients in
our study. This hypothesis is supported by a recent
study of 376 consecutive patients [5] showing that al-
though diabetic patients with non-Q-wave myocardial
infarction represented a cohort with more risk factors
for poor outcome, aggressive in-hospital revasculari-
sation with percutaneous coronary intervention result-
ed in excellent short-term outcome and 1-year sur-
vival similar to that in non-diabetic patients (92% vs
94%, NS). In addition, the beneficial effect of coro-
nary stenting compared with standard balloon angio-
plasty on vessel patency and long-term clinical out-
come in diabetic patients has now been demonstrated
conclusively [18].
We acknowledge that the revascularisation strategy
applied in UA/NSTEMI patients with three-vessel dis-
ease is controversial. In this study, coronary stenting
was not restricted to patients with one- and two-vessel
disease, but also favoured in patients with three-vessel
disease, if the target lesion seemed accessible. It is im-
portant to note that the benefit of percutaneous coro-
nary intervention over coronary artery bypass grafting
in UA/NSTEMI patients with diabetes and three-ves-
sel disease has yet to be proven. Although this inter-
vention is common in well-established centres, which
report an association with significantly lower morbidi-
ty, long-term outcome data from randomised trials
specifically including UA/NSTEMI patients are lack-
ing. In diabetic patients presenting with stable coro-
nary artery disease, coronary artery bypass grafting
seems to be more effective [19].
The treatment strategy applied in our patients is
novel in two ways: the timing of the intervention and
the preferred method of revascularisation. Coronary
angiography and subsequent coronary stenting of 
the culprit lesion, as the primary revascularisation
method, were performed within 24 hours of admission
in all patients. The percutaneous coronary intervention :
coronary artery bypass grafting ratio was 4:1. In the
FRISC II study, coronary angiography was performed
within the first 7 days and the percutaneous coronary
intervention : coronary artery bypass grafting ratio
was 1:1. In addition, the FRISC II study excluded pa-
tients with previous coronary artery bypass grafting,
and patients with advanced age. These differences
may explain the discrepant findings in multivariate
analysis with respect to the independent impact of dia-
betes mellitus on long-term mortality [13]. In the
FRISC II study, diabetes mellitus remained an inde-
pendent predictor of mortality at 12 months.
The prognostic impact of diabetes mellitus was 
different between women and men. Women with dia-
betes mellitus had similar long-term outcome to wom-
en without diabetes mellitus, whereas mortality was 
significantly increased in diabetic men compared with
non-diabetic men. This finding is in contrast to the ob-
servation of the OASIS registry, where diabetes melli-
tus was of greater prognostic importance for women
than for men. This may suggest that the association
between diabetes mellitus and sex depends on the
management strategy applied in UA/NSTEMI (very
early invasive vs conservative strategy). The very 
early invasive strategy seems to counteract and com-
pensate for many of the extra risk factors present in
diabetic women with UA/NSTEMI. The timing of the
revascularisation procedure may, at least in part, ex-
plain why diabetic women derived such a major bene-
fit from the management strategy applied in our study
compared with the management strategy applied in
OASIS. Although several pathophysiological distinc-
tions [20, 21, 22, 23, 24] have been reported between
women and men, the fact that women seem to form
fewer coronary collaterals than men [24] may be of
great importance. Due to this lack of collaterals, 
women may benefit particularly from a rapid correc-
tion of the epicardial obstruction during UA/NSTEMI
[25]. However, further study is necessary to confirm
this hypothesis.
Our analysis has four distinguishing features: (i) it is
derived from a prospective study of consecutive unse-
lected patients rather than from a randomised trial. This
eliminates selection bias and allows generalisation and
extrapolation of the findings into clinical practice; (ii) it
involves long-term follow-up; (iii) a uniform revascu-
larisation strategy was applied in all patients; and (iv)
the extent of coronary artery disease was quantified in
all patients and included in the multivariate analysis as
a potential cofounder. This enables us to investigate the
impact of diabetes mellitus, independent of the extent
of coronary artery disease at presentation.
In conclusion, diabetic patients with UA/NSTEMI
have more advanced coronary artery disease and more
severe UA/NSTEMI than non-diabetic patients. Con-
sequently, their in-hospital and long-term mortality is
higher. However, when a very early invasive strategy
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is applied, and after adjustment for baseline character-
istics, ECG findings, markers of inflammation and
myocardial necrosis, and the angiographic extent of
coronary artery disease, diabetes mellitus is no longer
an independent predictor of death.
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